Angiopoietin-2 Enhances Retinal Vessel Sensitivity to Vascular Endothelial Growth Factor

Journal of Cellular Physiology

Volumn 199, Issue 3, 2004, Pages 412-417

  Oshima, Yuji ^a   Deering, Tye ^a   Oshima, Sachiko ^a   Nambu, Hiroyuki ^a   Reddy, P Seshidhar ^b   Kaleko, Michael ^b,c   Connelly, Sheila ^b,c   Hackett, Sean F ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Advanced Vision Therapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN 2; DOXYCYCLINE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; GENE; GUTLESS ADENOVIRUS VECTOR; IRIS; IRIS NEOVASCULARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA BLOOD VESSEL; RETINA CAPILLARY; RETINA NEOVASCULARIZATION; TRANSGENIC MOUSE; VEGF GENE; VITREOUS BODY;

ADENOVIRIDAE; ANGIOPOIETIN-2; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; GENETIC VECTORS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; RETINA; RETINAL NEOVASCULARIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS MUSCULUS;

EID: 2342526664     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10442     Document Type: Article

References (16)

1. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, Miller JW. 1996. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization. Arch Ophthalmol 114:66-71.
2. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH. 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461.
3. Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA. 2000. Angiopoietin 2 expression in the retina: Upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275-284.
4. Miller JW, Stinson W, Folkman J. 1993. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 100:9-14.
5. Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D, Brough DE, Wei LL, Campochiaro PA. 2001. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253-263.
6. Ohno-Matsui K, Hirose A, Yamamoto S, Saikia J, Okamoto N, Gehlbach P, Duh EJ, Hackett SF, Chang M, Bok D, Zack DJ, Campochiaro PA. 2002. Inducible expression of vascular endothelial growth factor in photoreceptors of adult mice causes sever proliferative retinopathy and retinal detachment. Am J Pathol 160: 711-719.
7. Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA. 1997. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281-291.
8. Oshima Y, Tskahashi K, Oshima S, Saiahin Y, Saishin Y, Silva RL, Liang X, Reddy PS, Ganesh S, Brann T, Liau G, Kaleko M, Connelly S, Campochiaro PA. 2004. Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization. J Cell Physiol 199:399-411.
9. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, Oshima K. 1997. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64:505-517.
10. Ozaki H, Seo M-S, Ozaki K, Yamada H, Yamada E, Hofmann F, Wood J, Campochiaro PA. 2000. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156:679-707.
11. Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T, Pattison S, Golightly D, Idamakanti N, Pinkstaff A, Kaloss M, Barjot C, Chamberlain JS, Kaleko M, Connelly S. 2002. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol Ther 5:63-73.
12. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LES. 1996. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851-4856.
13. Seo M-S, Kwak N, Ozaki H, Yamada H, Okamoto N, Fabbro D, Hoffmann F, Wood JM, Campochiaro PA. 1999. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am J Pathol 154:1743-1753.
14. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA. 1998. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180-188.
15. Tolentino MJ, Miller JW, Gragoudas ES, Chatzistefanou K, Ferrara N, Adamis AP. 1996. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114:964-970.
16. Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA. 2002. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol 133:373-385.